Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 Oct;56(4):835–841. doi: 10.1172/JCI108162

The regulation of calcitonin in normal human plasma as assessed by immunoprecipitation and immunoextraction.

J G Parthemore, L J Deftos, D Bronzert
PMCID: PMC301938  PMID: 808561

Abstract

We have studied the secretion of calcitonin in normal adults with a new procedure of increased sensitivity for the measurement of the hormone in peripheral plasma. In this method, endogenous calcitonin is immunoprecipitated with specific antibodies from a 10-ml plasma sample. The calcitonin is then dissociated from the antibodies and extracted into alcohol. The alcohol is evaporated, and the calcitonin is recovered in assay diluent for subsequent radioimmunoassay. The procedure produces a fivefold increase in immunoassay sensitivity and eliminates plasma proteins which can produce spurious immunoassay effects. This procedure was used to measure calcitonin in normal adults. The mean (+/- SE) plasma calcitonin in 43 subjects was 10 (+/- 2) pg/ml. A+ the end of a 3-h calcium infusion (12 mg/kg), mean plasma calcitonin in 10 subjects had risen to 114 (+/- 21) pg/ml. In 11 subjects, a 10-min infusion of 150 mg of calcium caused calcitonin to rise to a mean concentration of 28 (+/- 7) pg/ml at 20 min. EDTA infusion (50 mg/kg 2 h) caused a slight decrease in plasma calcitonin. These results are consistent with our previous reports of the low concentrations of calcitonin in adult plasma. Our data may underestimate calcitonin levels since not all of the heterogenous species of hormone may be extracted by this method. In any case, this procedure has allowed us to determine that the low concentrations of plasma calcitonin in normal adults are responsive to perturbations of calcium homeostasis. The immunoextraction method may be applicable to other assays in which it is necessary to increase sensitivity or define specificity.

Full text

PDF
835

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clark M. B., Boyd G. W., Byfield P. G., Foster G. V. A radioimmunoassay for human calcitonin M. Lancet. 1969 Jul 12;2(7611):74–77. doi: 10.1016/s0140-6736(69)92389-7. [DOI] [PubMed] [Google Scholar]
  2. Deftos L. J., Bury A. E., Habener J. F., Singer F. R., Potts J. T., Jr Immunoassay for human calcitonin. II. Clinical studies. Metabolism. 1971 Dec;20(12):1129–1137. doi: 10.1016/0026-0495(71)90038-2. [DOI] [PubMed] [Google Scholar]
  3. Deftos L. J., Goodman A. D., Engelman K., Potts J. T., Jr Suppression and stimulation of calcitonin secretion in medullary thyroid carcinoma. Metabolism. 1971 Apr;20(4):428–431. doi: 10.1016/0026-0495(71)90105-3. [DOI] [PubMed] [Google Scholar]
  4. Deftos L. J. Immunoassay for human calcitonin. I. Method. Metabolism. 1971 Dec;20(12):1122–1128. doi: 10.1016/0026-0495(71)90037-0. [DOI] [PubMed] [Google Scholar]
  5. Deftos L. J., Powell D., Parthemore J. G., Potts J. T., Jr Secretion of calcitonin in hypocalcemic states in man. J Clin Invest. 1973 Dec;52(12):3109–3114. doi: 10.1172/JCI107510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Deftos L. J. Radioimmunoassay for calcitonin in medullary thyroid carcinoma. JAMA. 1974 Jan 28;227(4):403–406. [PubMed] [Google Scholar]
  7. Deftos L. J., Roos B. A., Bronzert D., Parthemore J. G. Immunochemical heterogeneity of calcitonin in plasma. J Clin Endocrinol Metab. 1975 Mar;40(3):409–412. doi: 10.1210/jcem-40-3-409. [DOI] [PubMed] [Google Scholar]
  8. Goltzman D., Potts J. T., Jr, Ridgway R. C., Maloof F. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma. N Engl J Med. 1974 May 9;290(19):1035–1039. doi: 10.1056/NEJM197405092901901. [DOI] [PubMed] [Google Scholar]
  9. Habener J. F., Mayer G. P., Powell D., Murray T. M., Singer F. R., Potts J. T., Jr Dextran-charcoal and dioxane phase separation methods in the radioimmunoassays for parathyroid hormone and calcitonin. Clin Chim Acta. 1973 May 18;45(3):225–233. doi: 10.1016/0009-8981(73)90431-2. [DOI] [PubMed] [Google Scholar]
  10. Hennessy J. F., Gray T. K., Cooper C. W., Ontjes D. A. Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in 2 patients with medullary carcinoma of the thyroid. J Clin Endocrinol Metab. 1973 Jan;36(1):200–203. doi: 10.1210/jcem-36-1-200. [DOI] [PubMed] [Google Scholar]
  11. Heynen G., Franchimont P. Human calcitonin radioimmunoassay in normal and pathological conditions. Eur J Clin Invest. 1974 Jun;4(3):213–222. doi: 10.1111/j.1365-2362.1974.tb00395.x. [DOI] [PubMed] [Google Scholar]
  12. Melvin K. E., Miller H. H., Tashjian A. H., Jr Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. N Engl J Med. 1971 Nov;285(20):1115–1120. doi: 10.1056/NEJM197111112852004. [DOI] [PubMed] [Google Scholar]
  13. Moukhtar M. S., Jullienne A., Tharaud D., Taboulet J., Milhaud G. Extraction et concentration de la calcitonine plasmatique humaine par des anticorps couplés sur support solide. C R Acad Sci Hebd Seances Acad Sci D. 1973 Jun 25;276(26):3445–3448. [PubMed] [Google Scholar]
  14. Parthemore J. G., Bronzert D., Roberts G., Deftos L. J. A short calcium infusion in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab. 1974 Jul;39(1):108–111. doi: 10.1210/jcem-39-1-108. [DOI] [PubMed] [Google Scholar]
  15. Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974 Oct;20(10):1255–1270. [PubMed] [Google Scholar]
  16. Samaan N. A., Hill C. S., Jr, Beceiro J. R., Schultz P. N. Immunoreactive calcitonin in medullary carcinoma of the thyroid and in maternal and cord serum. J Lab Clin Med. 1973 May;81(5):671–681. [PubMed] [Google Scholar]
  17. Silva O. L., Snider R. H., Becker K. L. Radioimmunoassay of calcitonin in human plasma. Clin Chem. 1974 Mar;20(3):337–339. [PubMed] [Google Scholar]
  18. Sizemore G. W., Hpeath H., 3rd, Larson J. M. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma. J Clin Invest. 1975 May;55(5):1111–1118. doi: 10.1172/JCI108012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tashijan A. H., Jr, Howland B. G., Melvin K. E., Hill C. S., Jr Immunoassay of human calcitonin. N Engl J Med. 1970 Oct 22;283(17):890–895. doi: 10.1056/NEJM197010222831702. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES